Baricitinib
An orally available small molecule drug with potential anti-inflammatory, immunomodulating, antineoplastic and antiviral activities. Baricitinib is a globally approved treatment for rheumatoid arthritis.
All edits by Rhys Davies
Edits on 21 Sep, 2021
Rhys Davies
Edits made to:
Article (+226 characters)
Article
Baricitinib | C16H17N7O2S | CID 44205240 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
Find more entities like Baricitinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.